The rosiglitazone controversy: the Indian perspective

J Assoc Physicians India. 2007 Jul:55:477-80.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Coronary Artery Disease / chemically induced
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Drug Evaluation / standards
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • India / epidemiology
  • Meta-Analysis as Topic
  • Rosiglitazone
  • Thiazolidinediones / adverse effects
  • Thiazolidinediones / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone